Moreover, we show that a treatment with Fingolimod is able to prevent the structural defects described in hippocampal neurons from the mouse models of two neurodevelopmental disorders, namely Rett syndrome and Cdkl5 deficiency disorder. This evidence concerns the gene CDKL5 and atypical Rett syndrome.